PENNSYLVANIA and NEW YORK: Tikun Olam, the world leader in cannabis science, and Ilera Healthcare, Pennsylvania’s premier medical marijuana cultivator, processor and dispenser, have finalized a deal to bring Tikun’s world-renowned medical marijuana strains to medical cannabis patients in the Keystone State later this year.
This partnership combines Tikun Olam’s history of peer-reviewed scientific research and unprecedented clinical data collection with Ilera’s expertise in formulating and delivering high-quality pharmaceutical-grade medical cannabis products to Pennsylvanians. Products developed from Tikun Olam’s proprietary strains, including its world-renowned Avidekel high-CBD strain, will be available in vape oils, tinctures and topical formulations.
Tikun Olam has created numerous cannabis strains designed to deliver symptomatic relief for specific conditions in line with the 17 medical conditions approved for medical cannabis use in Pennsylvania, including autism, cancer, PTSD, epilepsy, Crohn’s Disease/Colitis, chronic pain and neuropathy, to name a few.
“Tikun Olam has spent years developing our strains through scientific methods,” says Tikun CEO Bernie Sucher. “Finding the ideal partner that shares our focus on quality control and consistency from seed to sale was a top priority for our Pennsylvania launch, and Ilera Healthcare was our top choice.”
Greg Rochlin, CEO of Ilera Healthcare, sees this as a natural partnership. “Ilera is dedicated to producing consistent, high-quality medications with effects that are supported by data, and so is Tikun Olam.”